Jordan vs Kiribati: Treatment success rate for patients treated for MDR-TB
Jordan
100.0%
in 2022
Kiribati
100.0%
in 2022
Jordan rank
1st
Kiribati rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Jordan
- Kiribati
How they compare
Jordan currently reports 100.0% against 100.0% in Kiribati, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2015 it was Kiribati ahead.
Jordan ranks 1st and Kiribati ranks 1st of 163 countries.
Across the 2 decades both report, Jordan averaged higher in 1 and Kiribati in 1.
Head to head by decade
| Decade | Jordan | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.8% | 100.0% | 8.2% | Kiribati |
| 2020s | 100.0% | 91.5% | 8.5% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Jordan or Kiribati?
- Jordan, at 100.0% against 100.0% in Kiribati as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Jordan and Kiribati?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Kiribati?
- 6 years are reported by both, from 2015 to 2022.
- How do Jordan and Kiribati rank globally for treatment success rate for patients treated for mdr-tb?
- Jordan ranks 1st and Kiribati ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.